The company remains a wholly owned subsidiary of Hitachi Chemical Co., Ltd., which has announced its name change to Showa Denko Materials on October 1, 2020.
We are a leading global contract development and manufacturing organization (CDMO) dedicated to the advancement and manufacturing of gene and cell therapy products.
Derived from the Japanese word “mirai” meaning future, and the English word “miracle”, meaning “an extraordinary event”, our new name speaks to our goal to exceed the expectations of our customers.Learn More About Us
Our manufacturing development services help you design efficient and robust manufacturing processes for your cell and gene therapy.
We offer a comprehensive manufacturing experience that is fully compliant with the relevant regional regulatory requirements of our global facilities.
Stay up to date with Minaris Regenerative Medicine! View our press releases to read our latest news.
Whether in-person or virtually, read more about the events we will be attending to join our experts, meet out global team, and learn more about how we can help you manufacture your life changing therapeutics!